Pharmaceutical · Fiscal year end 12月末日

HEALIOS K.K.

4593

株式会社ヘリオス

FIGI BBG005NVKVP64593.T4593 JPCorp. no. 3290001055549

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-12

For the first half of the fiscal year to 2026-12: Revenue ¥0 billion (-75.0% YoY), Profit before tax ¥-2.3 billion, Net income ¥-2.3 billion.

	This period	Year on year
Revenue	¥15m	-75.0%
Profit before tax	−¥2.3bn	—
Net profit to owners	−¥2.3bn	—

From the securities report on EDINET, which states no forecast. History via /v1/companies/4593/earnings-releases.

Financials

IFRS · consolidated · fiscal year to 2025-12-31

Revenue: ¥104m
Net income: −¥2.2bn
ROE: -63.8%
Equity ratio: 28.7%
Dividend / share: —
Employees: 75

Revenue · ¥m

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2025-12-31	¥0.1bn	−¥2.2bn	¥17.1bn	¥4.9bn	-63.8%	¥-20.59	−¥3.2bn
2024-12-31	¥0.6bn	−¥4.2bn	¥14.2bn	¥2.1bn	-143.1%	¥-47.86	−¥1.8bn
2023-12-31	¥0.1bn	−¥3.8bn	¥15.2bn	¥3.9bn	-92.8%	¥-56.22	−¥2.8bn
2022-12-31	¥0.1bn	−¥5.2bn	¥15.0bn	¥4.4bn	-79.4%	¥-90.67	−¥4.6bn
2021-12-31	¥0.0bn	−¥4.9bn	¥24.0bn	¥8.6bn	-59.6%	¥-93.36	−¥5.1bn

Indicators

Computed by us from filings · fiscal year to 2025-12-31

Metric	Value	Percentile among listed companies
ROE, %	-63.8	0.7
Ordinary margin	-20.4423	0.2
Equity ratio, %	28.7	13.1
Revenue growth	-0.8143	0.2
Net income growth	0.4765	74.2
Operating cash flow / assets	-0.1856	2.8

Policy-uncertainty measure0.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 1 new 5% holder(s) in 180 days; net stake change −3.03pt in 90 days; 0.0% held by other listed companies.

Interest example: if all ¥2.0bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥10m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4593/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-03-24: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Latest voting result: 2026-03-25 · 資本金及び資本準備金の額の減少並びに剰余金の処分の件 · passed. /v1/companies/4593/voting

Ownership changes

All companies →

2026-11-06

Below 5%−1.52pt

Morgan Stanley & Co. International plc cut holdings in HEALIOS K.K. (4593) to 3.87% from 5.39%, below the 5% threshold.

S100ZCJBFiler profile Original filing (PDF, Japanese)
2026-10-21

Decrease−0.01pt

Morgan Stanley & Co. International plc reduced holdings in HEALIOS K.K. (4593) to 5.39% from 5.40%.

S100Z99NFiler profile Original filing (PDF, Japanese)
2026-10-06

Decrease−1.75pt

Morgan Stanley & Co. International plc reduced holdings in HEALIOS K.K. (4593) to 5.40% from 7.15%.

S100Z6GAFiler profile Original filing (PDF, Japanese)
2026-08-20

Increase+0.25pt

Morgan Stanley & Co. International plc raised holdings in HEALIOS K.K. (4593) to 7.15% from 6.90%.

S100YXRNFiler profile Original filing (PDF, Japanese)
2026-08-06

New 5% stake

Morgan Stanley & Co. International plc disclosed a 6.90% stake in HEALIOS K.K. (4593), crossing the 5% reporting threshold.

S100YUTIFiler profile Original filing (PDF, Japanese)
2026-07-06

Below 5%−3.63pt

Morgan Stanley & Co. International plc cut holdings in HEALIOS K.K. (4593) to 3.36% from 6.99%, below the 5% threshold.

S100YOW2Filer profile Original filing (PDF, Japanese)
2026-06-19

New 5% stake

Morgan Stanley & Co. International plc disclosed a 6.99% stake in HEALIOS K.K. (4593), crossing the 5% reporting threshold.

S100YF3OFiler profile Original filing (PDF, Japanese)
2026-02-20

Amendment+9.77pt

Athos Capital Limited filed a correction to a 5% report on HEALIOS K.K. (4593).

S100XML0Filer profile Original filing (PDF, Japanese)
2026-02-19

Increase+9.77pt

Athos Capital Limited raised holdings in HEALIOS K.K. (4593) to 30.52% from 20.75%.

S100XMDCFiler profile Original filing (PDF, Japanese)
2025-10-09

Amendment−2.55pt

individual filer filed a correction to a 5% report on HEALIOS K.K. (4593).

S100WTR5Original filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports

Bought SoldHover a dot for the trade

Holder	Period	Net shares	Net % of shares	Avg. filed price	Range
Athos Capital Limited	2024-02-09 – 2026-02-13	+47,156,500	+39.51pt	¥237.14	¥144–325
individual filer	2025-02-06 – 2025-08-15	+4,130,000	+4.65pt	¥587	¥587–587
Maven Investment Partners Ltd	2023-08-07 – 2025-05-13	+5,513,900	+7.14pt	¥248.09	¥185–276
Heights Capital Management, Inc.	2023-08-07 – 2024-02-02	+3,440,100	+4.45pt	¥214.6	¥135–276
J.P. Morgan Securities plc	2023-06-13 – 2023-10-09	+1,700	0.00pt	—	—
JPモルガン証券株式会社	2023-06-12 – 2023-10-06	-23,534	+0.02pt	¥246.89	¥220–320
J.P. Morgan Securities LLC	2023-06-12 – 2023-09-26	0	0.00pt	—	—
JPモルガン・アセット・マネジメント株式会社	2023-06-13 – 2023-07-13	+2,900	0.00pt	—	—
NOMURA INTERNATIONAL PLC	2022-06-06 – 2022-09-16	-423,800	−0.78pt	¥356.94	¥301–425
野村證券株式会社	2022-06-06 – 2022-09-16	+4,320,600	+6.81pt	¥324.88	¥302–423
individual filer	2021-12-22 – 2021-12-23	+65,300	+0.12pt	¥1,351.55	¥1,344–1,360

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4593/trades.

5% filings

Large shareholding reports on 4593

Filed	Filer	Stake	Change	Stated purpose
2026-11-06	Morgan Stanley & Co. International plc	3.87%	−1.52pt	—
2026-10-21	Morgan Stanley & Co. International plc	5.39%	−0.01pt	—
2026-10-06	Morgan Stanley & Co. International plc	5.40%	−1.75pt	—
2026-09-04	Morgan Stanley & Co. International plc	7.15%	0.00pt	—
2026-08-20	Morgan Stanley & Co. International plc	7.15%	+0.25pt	—
2026-08-06	Morgan Stanley & Co. International plc	6.90%	—	—
2026-07-06	Morgan Stanley & Co. International plc	3.36%	−3.63pt	—
2026-06-19	Morgan Stanley & Co. International plc	6.99%	—	—
2026-02-20	Athos Capital Limited	30.52%	+9.77pt	pure investment
2026-02-19	Athos Capital Limited	30.52%	+9.77pt	pure investment

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: — issues
Book value: —
Sold in the year: — — issues
Bought in the year: — — issues
Mutual, both reports: 0
Held by listed cos.: 1

Held by: NIKON CORPORATION 7731

Purposes, all holdings and mutual flags via /v1/companies/4593/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31

Shareholder	Shares	Ratio
individual holder	27,830,300	24.05%
MSIP CLIENT SECURITIES	6,069,463	5.24%
BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC)	4,353,641	3.76%
GOLDMAN,SACHS & CO.REG	3,564,796	3.08%
BNYM SA/NV FOR BNYM FOR BNYM GCM CLIENT ACCTS M ILM FE	3,279,802	2.83%
楽天証券株式会社共有口	2,798,400	2.42%
BBH(LUX) FOR FIDELITY FUNDS - PACIFIC POOL	2,177,900	1.88%
株式会社ＳＢＩ証券	2,151,024	1.86%
株式会社ＲＡＣＴＨＥＲＡ	1,500,000	1.30%
ＪＰモルガン証券株式会社	1,236,387	1.07%

U.S. funds holding 4593

SEC Form N-PORT, reports to 2026-05-31

1 U.S. funds held 4,400 shares worth $0.0m.

Fund	Shares	Value	% of fund	As of
Avantis International Small Cap Equity ETF American Century ETF Trust	4,400	$0.0m	0.003%	2026-05-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4593
GET /v1/companies/4593/financials
GET /v1/companies/4593/details
GET /v1/companies/4593/segments
GET /v1/companies/4593/voting
GET /v1/companies/4593/tender-offers
GET /v1/companies/4593/indicators
GET /v1/companies/4593/earnings-releases
GET /v1/events?ticker=4593
GET /v1/companies/4593/trades         
GET /v1/companies/4593/cross-holdings 
GET /v1/companies/4593/brief

Plans from $9 a month · Documentation